Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Jennison Associates LLC reported a 9.60% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 8, 2025
Jennison Associates LLC reported a 9.60% stake in Arcutis Biotherapeutics, Inc., 11,360,875 shares, as a passive investor on Mar 31, 2025. Filed May 8, 2025 (Schedule 13G/A).
- Stake
- 9.60%
- Shares
- 11,360,875
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Jennison Associates LLC | 9.60% | 11,360,875 |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Jennison Associates LLC
- Arcutis Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Jennison Associates LLC · May 6, 2026
- Schedule 13G/A · Jennison Associates LLC · Jan 30, 2026
- Schedule 13G/A · Jennison Associates LLC · Oct 6, 2025
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026